Retour aux projets

25390.2 PFLS-LS

Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.

Résumé

Modelling and preclinical verification of a diagnostic and therapeutic approach to treat microvascular obstructions in heart attack patients.

Textes supplémentaires

Abstract

A major cardiovascular unmet medical need today is the peri#procedural diagnosis and treatment of microvascular obstructions (MVO). MVO occurs in 40% # 60% of acute myocardial infarction with STsegment elevations patients treated with a stent. Current therapeutic options remain limited with non#standardized approaches attempting to clear the MVO#s. ReFlow Therapeutics aims at developing the first diagnostic and therapeutic medical device that can diagnose and treat MVO while the patient is still in the catheter laboratory after a stent.

Participants

Dominik Obrist

Kontaktperson

dominik.obrist@artorg.unibe.ch

Universität Bern ARTORG Center Dominik Obrist Murtenstrasse 50 3008 Bern BE CH

Jon H. Hoem

Wirtschaftspartner

jhoem@reflow-therapeutics.ch

ReFlow Therapeutics AG Jon H. Hoem Neuhofstrasse 5a 6340 Baar ZG CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2017-02-28
Date de fin
2018-08-31
Coûts totaux approuvés
CHF 823925.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T115 Medical technology 100.0%